Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 1 · 33.3%Very low 2 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

DOPAMINERGIC DRUGS vs placebo

Secondary outcome: acceptability of treatment · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether DOPAMINERGIC DRUGS changes acceptability of treatment: Leaving the study early compared with PLACEBO (very low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 1.29 [0.65, 2.54]
6 studies · 163 participants
Very low

DOPAMINERGIC DRUGS vs other drugs

Secondary outcome: acceptability of treatment · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether DOPAMINERGIC DRUGS changes acceptability of treatment: Leaving the study early compared with OTHER DRUGS (very low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.23 [0.01, 4]
1 study · 13 participants
Very low

NORADRENERGIC DRUGS vs DOPAMINERGIC DRUGS

Secondary outcome: acceptability of treatment · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported